Hospital News, Industry News, Press, Tru-D News, Tru-D Technology, Uncategorized

Tru-D Featured in Outpatient Surgery Magazine

Two of our hospital partners, St. Charles- Bend and Mission Hospital, were recently featured in an article in Outpatient Surgery Magazine.  In January, St. Charles-Bend brought in Tru-D for a 45-day trial. Satisfied with the results of reducing hospital-acquired infections (HAIs) without impeding room turnovers, the hospital now intends to

Read More
Posted 05.16.17
  • Share

Hospital News, Industry News, Press, Tru-D News, Tru-D Technology, Uncategorized

From Duke Health: UVC Light Helps Hospitals Fight Drug-Resistant Superbugs

From Clinical Practice Today by Duke Health:

Read More
Posted 05.10.17
  • Share

Industry News, Press, Studies, Tru-D News, Tru-D Technology

Tru-D SmartUVC Proven to Reduce Bioburden in Operating Rooms

A recent study published in the American Journal of Infection Control, Ultraviolet-C light as a means of disinfecting anesthesia workstations, demonstrated Tru-D SmartUVC’s ability to reduce bioburden on anesthesia workstations. In the study, UVC disinfection greatly influenced bioburden reduction on high-touch, complex medical equipment surfaces contaminated with three (3) organisms

Read More
Posted 05.04.17
  • Share

Tru-D News, Uncategorized

Tru-D Hires Clinical Affairs Director

Image of Ralph Taylor

Tru-D SmartUVC, a leader in the ultraviolet (UV) disinfection space, has hired a Director of Clinical Affairs. Ralph Taylor, RN, MSN, MHA, CNOR has joined the Tru-D team to expand the success of the company’s approach to enhanced UV disinfection throughout the U.S. As Director of Clinical Affairs, Taylor will

Read More
Posted 05.02.17
  • Share

Industry News, Studies, Tru-D News, Tru-D Technology, Uncategorized

BETR-D Study Shows 11% C. diff Reduction

Shield Design with 11% Hospital C. Diff Reduction

The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study is the first and only randomized clinical trial on UV disinfection. The study’s primary outcome showed that enhanced terminal room disinfection strategies that utilized Tru-D reduced the risk of acquisition and infection by a cumulative 30 percent among patients who entered the

Read More
Posted 04.26.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »